Sobi

Highly Engaged Employees

Sobi is a prominent international biopharmaceutical company established in 2011 and headquartered in Stockholm, Sweden. The firm specializes in the development of innovative therapies targeting rare diseases, with a primary research focus on hematology and immunology. By leveraging advanced biotechnology and in-house research capabilities, Sobi delivers specialized healthcare solutions designed to improve patient outcomes across global markets. The company operates as a value-driven entity, focusing on the intersection of medical science and patient-centric care to address complex health conditions.

The organization maintains a robust operational footprint with 3 locations worldwide. Sobi supports its extensive research and development initiatives with a diverse workforce of 1,000-5,000 employees, including specialized teams of scientists, engineers, and medical professionals dedicated to pioneering new treatments. The company’s operational structure is designed to facilitate rapid innovation in the biopharmaceutical sector. Meet Sobi's team to gain deeper insights into the leadership, organizational structure, and the technical expertise driving their ongoing biopharmaceutical advancements and clinical research programs.

Financially, Sobi demonstrates a significant market presence, reporting annual revenue of $3.0B. The company has successfully secured capital through strategic stock issuances and debt financing, including support from major institutional investors like Investor AB and Svenska Handelsbanken. This financial stability allows Sobi to continue its investment in high-impact medical research and global expansion efforts. Explore financial highlights to review detailed performance metrics, historical funding data, and the company's fiscal trajectory within the competitive pharmaceutical landscape.